Bills

SB 873: Prescription drugs: cost sharing.

  • Session Year: 2023-2024
  • House: Senate

Current Status:

Failed

(2023-09-01: September 1 hearing: Held in committee and under submission.)

Introduced

First Committee Review

First Chamber

Second Committee Review

Second Chamber

Enacted

Version:

(1)Existing law, the Knox-Keene Health Care Service Plan Act of 1975, provides for the licensure and regulation of health care service plans by the Department of Managed Health Care under authority of the Director of the Department of Managed Health Care and makes a willful violation of the act a crime. Existing law provides for the regulation of health insurers by the Department of Insurance under the authority of the Insurance Commissioner. Existing law limits the maximum amount an enrollee or insured may be required to pay at the point of sale for a covered prescription drug to the lesser of the applicable cost-sharing amount or the retail price.

This bill, commencing no later than January 1, 2025, would require an enrollees or insureds defined cost sharing for each prescription drug to be calculated at the point of sale based on a price that is reduced by an amount equal to 90% of all rebates received, or to be received, in connection with the dispensing or administration of the drug. The bill would require a health care service plan or health insurer to, among other things, pass through to each enrollee or insured at the point of sale a good faith estimate of the enrollees or insureds decrease in cost sharing. The bill would require a health care service plan or health insurer to calculate an enrollees or insureds defined cost sharing and provide that information to the dispensing pharmacy, as specified. The bill would require the department and the commissioner to submit an annual report on the impact of these provisions to the appropriate policy committees of the Legislature, as specified. The bill would make these provisions inoperative on January 1, 2027.

(2)Existing law requires a health care service plan or health insurer that files certain rate information to report to the appropriate department specified cost information regarding covered prescription drugs, including generic drugs, brand name drugs, and specialty drugs, dispensed as provided.

This bill, until January 1, 2027, would require a health care service plan or health insurer to report additional information on the above-described point of sale provision.

(3)Because a willful violation of the bills provisions by a health care service plan would be a crime, the bill would impose a state-mandated local program.

The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.

This bill would provide that no reimbursement is required by this act for a specified reason.

Discussed in Hearing

Assembly Standing Committee on Health42MIN
Jul 11, 2023

Assembly Standing Committee on Health

Senate Floor3MIN
May 31, 2023

Senate Floor

Senate Standing Committee on Appropriations1MIN
May 1, 2023

Senate Standing Committee on Appropriations

Senate Standing Committee on Health22MIN
Apr 19, 2023

Senate Standing Committee on Health

View Older Hearings

News Coverage:

SB 873: Prescription drugs: cost sharing. | Digital Democracy